Voice2Voice™ -- the advocacy program for new Vivaglobin® patients and caregivers

Our client CSL Behring has launched a consumer outreach program offering peer-to-peer support to primary immunodeficiency patients and caregivers.

We helped brand it as Voice2Voice™

The program will offer assistance to new patients as they begin at-home use of Vivaglobin®, the first and only FDA-approved sub-Q Ig.

Through Voice2Voice, a third party assigns new patients and caregivers their own personal advocate (a patient experienced in self-administering Vivaglobin) who will call them to help ease the transition to at-home self-administration. The advocate’s phone call strives to help new patients and caregivers understand what Vivaglobin therapy entails, to promote sharing of personal experiences with the treatment, to answer any non-medical infusion questions that might arise, and to offer encouragement.

For more information about Vivaglobin therapy, visit http://www.vivaglobin.com/